Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Psychiatry Res ; 299: 113806, 2021 05.
Article in English | MEDLINE | ID: mdl-33667947

ABSTRACT

Little is known about the use of mental health smartphone applications during the greatest period of vulnerability - immediately following discharge from a psychiatric inpatient unit. Currently, no data are available regarding smartphone ownership or technology literacy of individuals who receive inpatient psychiatric treatment. The goal of this study was to determine psychiatric inpatients' smartphone ownership, current uses of, and interest in utilizing apps to aid in mental health treatment after discharge. A single time point self-report survey was given to patients prior to discharge from a psychiatric inpatient unit at a major academic hospital in a metropolitan area of the United States. Of the 101 survey respondents, 82.8% indicated that they own a smartphone, and over 70% indicated that they use smartphone apps, can access the internet from their phones, and use social media. While only 25.3% reported that they currently use a mental health app, a majority of respondents (53.2%) expressed interest in using such apps in the future, and almost 60% would use those apps to track their mental health. Our data suggest that there is significant untapped potential for utilizing smartphone applications for psychiatric monitoring and treatment following discharge from an inpatient psychiatric unit.


Subject(s)
Inpatients , Mobile Applications , Humans , Mental Health , Ownership , Smartphone
2.
Endoscopy ; 48(8): 711-6, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27129136

ABSTRACT

BACKGROUND AND STUDY AIM: Adoption of endoscopic submucosal dissection (ESD) in Western countries has been limited by the difficulty in learning the procedure. Although a porcine model is commonly used for ESD training, without expert guidance the procedure is difficult to master. The availability of Western ESD experts is limited, and expert supervision through a remote video-based system may be a practical method for Western endoscopists to learn ESD. The aim of this study was to assess the value of video-based remote evaluation in supervising ESD training. METHODS: Two Western endoscopists performed ESD training procedures in an ex vivo porcine model at least every 2 weeks until competency was achieved. Competency was defined as consistent en bloc resection of a 3-cm area within 30 minutes, and without perforation, using the proper ESD technique. A Japanese ESD expert at the National Cancer Center in Tokyo, Japan, analyzed the training videos, scored them, and provided written feedback for improvement after each training session and before the trainee's next training session. RESULTS: Endoscopist 1 reached competency at 23 procedures and endoscopist 2 reached competency at 25 procedures. No difference in skill improvement between the two endoscopists was noted. One trainee subsequently completed eight ESD procedures in patients, with curative en bloc resection and no complications. CONCLUSION: A standardized ESD training program including educational presentations/videos and preclinical animal training with expert guidance through a remote video-based system is an effective tool for learning ESD techniques in preparation for performing the procedure in humans.


Subject(s)
Clinical Competence , Endoscopic Mucosal Resection/education , Teaching , Video Recording , Animals , Endoscopic Mucosal Resection/instrumentation , Endoscopic Mucosal Resection/methods , Feedback , Humans , Japan , Learning Curve , Operative Time , Swine , United States
3.
Gastrointest Endosc ; 84(4): 597-603, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26646671

ABSTRACT

BACKGROUND AND AIMS: A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. METHODS: Plasma samples were collected from subjects with EAC and GERD before endoscopy. Twenty-two preselected VOCs were analyzed with selected ion flow tube mass spectrometry. RESULTS: The headspaces from 39 plasma samples (20 EAC, 19 GERD) were analyzed. The levels of 9 VOCs (acetonitrile, acrylonitrile, carbon disulfide, isoprene, 1-heptene, 3-methylhexane, [E]-2-nonene, hydrogen sulfide, and triethylamine) were significantly altered in EAC patients compared with GERD patients. A multivariable logistic regression analysis was performed to build a model for the prediction of EAC. The model identified patients with EAC with an area under the curve of 0.83 (95% confidence interval, 0.67-0.98). CONCLUSIONS: Plasma VOCs may be useful in diagnosing EAC. Larger studies are needed to confirm our pilot study observations.


Subject(s)
Adenocarcinoma/blood , Esophageal Neoplasms/blood , Volatile Organic Compounds/blood , Acetonitriles/blood , Acrylonitrile/blood , Adenocarcinoma/diagnosis , Adult , Aged , Area Under Curve , Butadienes/blood , Carbon Disulfide/blood , Case-Control Studies , Cross-Sectional Studies , Endoscopy, Digestive System , Esophageal Neoplasms/diagnosis , Ethylamines/blood , Female , Gastroesophageal Reflux/blood , Gastroesophageal Reflux/diagnosis , Hemiterpenes/blood , Hexanes/blood , Humans , Hydrogen Sulfide/blood , Logistic Models , Male , Middle Aged , Multivariate Analysis , Pentanes/blood , Pilot Projects
4.
ACG Case Rep J ; 3(1): 57-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26504881

ABSTRACT

We present a 42-year-old man with a 1-month history of painless jaundice, dark urine, clay-colored stools, and a 13.5-kg weight loss. Laboratory tests revealed elevated liver enzymes and CA19-9. Imaging showed dilation of both the intra- and extrahepatic bile ducts, narrowing of the bile duct at the junction of the common bile duct and common hepatic duct, and a hypoechoic mass involving the neck of the gallbladder and the muscularis propria of the duodenum. Examination of the resected gallbladder and perihilar nodes ruled out malignancy and revealed a diffuse inflammatory infiltrate of giant histiocytes with clear, lipid-containing cytoplasm (xanthoma cells), consistent with xanthogranulomatous cholecystitis.

5.
Clin Gastroenterol Hepatol ; 13(8): 1496-501, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25818080

ABSTRACT

BACKGROUND & AIMS: Most patients with acute pancreatitis (AP) develop mild disease, but up to 20% develop severe disease. Many clinicians monitor serum levels of amylase and lipase in an attempt to predict the disease course, but this strategy has not been recommended by practice guidelines. We performed a retrospective analysis to determine whether the percentage changes in amylase and lipase were associated with the severity of disease that developed in patients with AP. METHODS: We analyzed data collected from 182 consecutive patients with AP (21 with severe AP) admitted to the Cleveland Clinic from January 2008 through May 2010 (discover cohort). The association between 11 different factors and the severity of AP were assessed by univariable analysis; multivariable models were explored through stepwise selection regression. The percentage change in the serum level of amylase was calculated as follows: ([amylase day 1 - amylase day 2]/amylase day 1) × 100. The percentage change in amylase and body mass index (BMI) were combined to generate a z-score (z = -5.9 + [0.14 × BMI] + [0.01 × percentage change in amylase]), which was converted into a probability distribution called the change in amylase and BMI (CAB) score. The CAB score was validated using the AP database at the University of Pittsburgh Medical Center (140 patients, 35 with severe AP); we calculated p-scores for each patient and estimated the area under the receiver operating characteristics curve values. RESULTS: Univariable analysis identified the percentage change in the serum level of amylase and other factors to be associated significantly with the severity of AP (P = .017). The CAB score was best at identifying patients who developed severe AP, with an area under the receiver operating characteristics curve value of 0.79 in the discovery cohort (95% confidence interval, 0.71-0.87) and 0.731 in the validation cohort (95% confidence interval, 0.61-0.84). CONCLUSIONS: We developed a model to identify patients most likely to develop severe AP based on the percentage changes in serum level of amylase during the first 2 days after admission to the hospital and BMI.


Subject(s)
Amylases/blood , Body Mass Index , Pancreatitis, Acute Necrotizing/diagnosis , Pancreatitis, Acute Necrotizing/pathology , Serum/enzymology , Severity of Illness Index , Adult , Aged , Decision Support Techniques , Female , Humans , Male , Middle Aged , Retrospective Studies
6.
Am J Gastroenterol ; 110(6): 784-91, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25623656

ABSTRACT

Endoscopic submucosal dissection (ESD) allows for curative resection of superficial neoplasms of the gastrointestinal tract. Although ESD is the standard of care in Japan, its adoption in the West has been slow. Recent studies have shown the advantages of ESD over endoscopic mucosal resection, and as many of the barriers to ESD have been overcome, we are seeing an increasing interest in this technique. ESD can be used to treat superficial gastric, esophageal, and colorectal lesions. The most important pre-procedure step is estimating the depth of invasion of a lesion and by proxy the risk of lymph node metastasis. After a lesion has been resected, the histopathological analysis will determine whether the resection was curative or whether further surgery is needed. In conclusion, ESD is being more widely used in the West, and it is important to understand the indications, limitations, and techniques of ESD.


Subject(s)
Colorectal Neoplasms/surgery , Dissection/methods , Endoscopy, Gastrointestinal/methods , Esophageal Neoplasms/surgery , Gastric Mucosa/surgery , Intestinal Mucosa/surgery , Stomach Neoplasms/surgery , Colorectal Neoplasms/pathology , Esophageal Neoplasms/pathology , Gastric Mucosa/pathology , Humans , Intestinal Mucosa/pathology , Mucous Membrane/pathology , Mucous Membrane/surgery , Neoplasm Invasiveness , Stomach Neoplasms/pathology
7.
Gastroenterol Rep (Oxf) ; 2(4): 281-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25085954

ABSTRACT

BACKGROUND AND AIMS: Barrett's esophagus (BE) and colorectal neoplasms share similar risk factors. Previous studies have shown variable prevalence of colon polyps in patients with BE. Our aims were to determine the prevalence and incidence of colon polyps in patients with BE, compared to those without BE. METHODS: In this case-control study, the study group included patients, aged 50-75 years, with biopsy-proven BE, who underwent colonoscopy at Cleveland Clinic from January 2002 to December 2011. The control group consisted of age- and sex-matched patients who underwent colonoscopy and also an endoscopy with no evidence of BE during the same time period. Exclusion criteria for both groups were family- or personal previous history of colon cancer or polyps, prior colonic resection, inflammatory bowel disease and familial polyposis syndromes. Patient demographics, comorbidities, medication use and endoscopic and colonoscopic details were collected, including biopsy results. RESULTS: A total of 519 patients were included in the study; 173 patients with BE in the study group and 346 without BE in the control group. Mean age at index colonoscopy was 61 ± 8 years and 75% of patients were male. On index colonoscopy, patients with BE were more likely to have polyps than controls (45% vs 32%, respectively; P = 0.003). Patients underwent between one and five colonoscopies during the follow-up. On multivariate analysis-after adjusting for age, gender and diabetes-patients with BE were 80% more likely to have any type of polyp, and 50% more likely to have adenomas found during colonoscopy. CONCLUSIONS: Patients with BE had higher prevalence and incidence of colon polyps. This has important clinical implications for screening and surveillance in BE patients.

8.
Obes Surg ; 24(12): 2025-30, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24972683

ABSTRACT

BACKGROUND: The incidence of acute pancreatitis (AP) in bariatric surgery patients is not known. Ouraim was to determine the incidence, outcomes, and risk factors of AP in post-bariatric surgery patients. METHODS: An historical cohort study was conducted of all patients who underwent Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding, and revisional procedures at our institution from January 2004 to September 2011. Patients who developed AP were identified by review of the electronic medical record. A nested case-control study using Cox regression analysis was done to identify risk factors. RESULTS: A total of 2695 patients underwent bariatric surgery. Twenty-eight patients (1.04 %) developed AP during a median follow-up of 3.5 years (interquartile range [IQR] 1.9-5.8). One patient had severe AP, and there was one AP-related death. In the case-control study, the only baseline variable that predicted post-operative AP was a prior history of AP. Three other variables identified after surgery were associated with AP: (1) rapid weight loss as measured by percent of excess weight loss (EWL) at the first post-operative visit, (2) abnormal findings on post-operative ultrasound (stones, sludge or ductal dilation), and (3) post-operative complications of bowel leak or anastomotic stricture. CONCLUSIONS: The incidence of AP in this cohort is 1.04 %, which is higher than that reported for the general population (~17/100,000, 0.017 %). Most cases were clinically mild and managed conservatively with good outcomes. Rapid post-operative weight loss and the presence of gallstones or sludge on post-operative ultrasound were significant risk factors for AP.


Subject(s)
Bariatric Surgery/adverse effects , Obesity, Morbid/surgery , Pancreatitis/epidemiology , Postoperative Complications/epidemiology , Adult , Bariatric Surgery/methods , Case-Control Studies , Cohort Studies , Female , Humans , Incidence , Male , Middle Aged , Ohio/epidemiology , Pancreatitis/etiology , Postoperative Complications/etiology , Risk Factors
9.
Clin Gastroenterol Hepatol ; 11(5): 511-6, 2013 May.
Article in English | MEDLINE | ID: mdl-23305824

ABSTRACT

BACKGROUND & AIMS: Celiac disease is underdiagnosed, with nonspecific symptoms and high morbidity. New diagnostic factors are needed. We aimed to estimate the frequency at which adult patients with positive results from serology tests are referred for small-bowel biopsies and to identify factors that improve the diagnosis of celiac disease. METHODS: We performed a retrospective analysis of data from 2477 subjects who received serology tests for celiac disease between 2005 and 2007. We analyzed results for total levels of IgA, IgA against human tissue transglutaminase (hTTG), IgA and IgG against gliadin, as well as dilution titers of IgA against endomysial antibodies (EMA). Biopsy samples were analyzed by pathologists experienced in detecting mucosal changes associated with celiac disease and graded according to the Marsh system. RESULTS: Of the 2477 patients, 610 (25%) had abnormal results from serology tests, and 39% of these patients (240 of 610) underwent small-bowel biopsy analyses. Of these patients, 50 (21%) had biopsy findings consistent with celiac disease (Marsh 3 lesions) and were placed on gluten-free diets. Titers of IgA hTTG greater than 118 U identified patients with celiac disease with a 2% false-positive rate. Titers of 21 to 118 U, in combination with an EMA dilution titer of 1:160 or greater, had a positive predictive value of 83% for celiac disease. IgA hTTG levels less than 20 U, in combination with an EMA dilution titer less than 1:10, had a negative predictive value of 92% for celiac disease. CONCLUSIONS: Serum levels of IgA hTTG greater than 118 U, or 21 to 118 U in combination with an EMA dilution titer of 1:160 or greater, can be used to identify adult symptomatic patients with celiac disease, in the absence of a small-bowel biopsy.


Subject(s)
Celiac Disease/diagnosis , Adult , Aged , Autoantibodies/blood , Female , Gliadin/immunology , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Middle Aged , Retrospective Studies , Serologic Tests/methods , Transglutaminases/immunology
10.
J Clin Invest ; 122(8): 2807-16, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22751103

ABSTRACT

Genome-wide association studies (GWAS) have identified a genetic variant at a locus on chromosome 1p13 that is associated with reduced risk of myocardial infarction, reduced plasma levels of LDL cholesterol (LDL-C), and markedly increased expression of the gene sortilin-1 (SORT1) in liver. Sortilin is a lysosomal sorting protein that binds ligands both in the Golgi apparatus and at the plasma membrane and traffics them to the lysosome. We previously reported that increased hepatic sortilin expression in mice reduced plasma LDL-C levels. Here we show that increased hepatic sortilin not only reduced hepatic apolipoprotein B (APOB) secretion, but also increased LDL catabolism, and that both effects were dependent on intact lysosomal targeting. Loss-of-function studies demonstrated that sortilin serves as a bona fide receptor for LDL in vivo in mice. Our data are consistent with a model in which increased hepatic sortilin binds intracellular APOB-containing particles in the Golgi apparatus as well as extracellular LDL at the plasma membrane and traffics them to the lysosome for degradation. We thus provide functional evidence that genetically increased hepatic sortilin expression both reduces hepatic APOB secretion and increases LDL catabolism, providing dual mechanisms for the very strong association between increased hepatic sortilin expression and reduced plasma LDL-C levels in humans.


Subject(s)
Adaptor Proteins, Vesicular Transport/metabolism , Apolipoproteins B/metabolism , Lipoproteins, LDL/metabolism , Liver/metabolism , APOBEC-1 Deaminase , Adaptor Proteins, Vesicular Transport/genetics , Animals , Apolipoproteins B/genetics , Base Sequence , Cell Line , Cytidine Deaminase/deficiency , Cytidine Deaminase/genetics , DNA Primers/genetics , Humans , Hydrogen-Ion Concentration , Kinetics , Lipoproteins, VLDL/metabolism , Lysosomes/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Models, Biological , Mutagenesis, Site-Directed , Receptors, LDL/deficiency , Receptors, LDL/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
11.
PLoS One ; 7(2): e31616, 2012.
Article in English | MEDLINE | ID: mdl-22363685

ABSTRACT

Apolipoprotein F (apoF) is 29 kilodalton secreted sialoglycoprotein that resides on the HDL and LDL fractions of human plasma. Human ApoF is also known as Lipid Transfer Inhibitor protein (LTIP) based on its ability to inhibit cholesteryl ester transfer protein (CETP)-mediated transfer events between lipoproteins. In contrast to other apolipoproteins, ApoF is predicted to lack strong amphipathic alpha helices and its true physiological function remains unknown. We previously showed that overexpression of Apolipoprotein F in mice reduced HDL cholesterol levels by 20-25% by accelerating clearance from the circulation. In order to investigate the effect of physiological levels of ApoF expression on HDL cholesterol metabolism, we generated ApoF deficient mice. Unexpectedly, deletion of ApoF had no substantial impact on plasma lipid concentrations, HDL size, lipid or protein composition. Sex-specific differences were observed in hepatic cholesterol content as well as serum cholesterol efflux capacity. Female ApoF KO mice had increased liver cholesteryl ester content relative to wild type controls on a chow diet (KO: 3.4+/-0.9 mg/dl vs. WT: 1.2+/-0.3 mg/dl, p<0.05). No differences were observed in ABCG1-mediated cholesterol efflux capacity in either sex. Interestingly, ApoB-depleted serum from male KO mice was less effective at promoting ABCA1-mediated cholesterol efflux from J774 macrophages relative to WT controls.


Subject(s)
Apolipoproteins/deficiency , Cholesterol, HDL/metabolism , Animals , Apolipoproteins/metabolism , Biological Transport , Cholesterol, HDL/blood , Diet, High-Fat , Feeding Behavior , Female , Genes, Reporter , Glycosylation , HEK293 Cells , Humans , Male , Mice , Mice, Knockout , Molecular Weight , Protein Processing, Post-Translational , Staining and Labeling , beta-Galactosidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...